Fetal lung underdevelopment is rescued by administration of amniotic fluid stem cell extracellular vesicles in rodents.


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
21 04 2021
Historique:
received: 08 04 2019
revised: 04 03 2020
accepted: 28 12 2020
entrez: 22 4 2021
pubmed: 23 4 2021
medline: 13 7 2021
Statut: ppublish

Résumé

Fetal lung underdevelopment, also known as pulmonary hypoplasia, is characterized by decreased lung growth and maturation. The most common birth defect found in babies with pulmonary hypoplasia is congenital diaphragmatic hernia (CDH). Despite research and clinical advances, babies with CDH still have high morbidity and mortality rates, which are directly related to the severity of lung underdevelopment. To date, there is no effective treatment that promotes fetal lung growth and maturation. Here, we describe a stem cell-based approach in rodents that enhances fetal lung development via the administration of extracellular vesicles (EVs) derived from amniotic fluid stem cells (AFSCs). Using fetal rodent models of pulmonary hypoplasia (primary epithelial cells, organoids, explants, and in vivo), we demonstrated that AFSC-EV administration promoted branching morphogenesis and alveolarization, rescued tissue homeostasis, and stimulated epithelial cell and fibroblast differentiation. We confirmed this regenerative ability in in vitro models of lung injury using human material, where human AFSC-EVs obtained following good manufacturing practices restored pulmonary epithelial homeostasis. Investigating EV mechanism of action, we found that AFSC-EV beneficial effects were exerted via the release of RNA cargo. MicroRNAs regulating the expression of genes involved in lung development, such as the miR17-92 cluster and its paralogs, were highly enriched in AFSC-EVs and were increased in AFSC-EV-treated primary lung epithelial cells compared to untreated cells. Our findings suggest that AFSC-EVs hold regenerative ability for underdeveloped fetal lungs, demonstrating potential for therapeutic application in patients with pulmonary hypoplasia.

Identifiants

pubmed: 33883273
pii: 13/590/eaax5941
doi: 10.1126/scitranslmed.aax5941
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Lina Antounians (L)

Developmental and Stem Cell Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, M5G 0A4, Canada.
Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, M5G 1X8, Canada.

Vincenzo D Catania (VD)

Developmental and Stem Cell Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, M5G 0A4, Canada.
Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, M5G 1X8, Canada.

Louise Montalva (L)

Developmental and Stem Cell Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, M5G 0A4, Canada.
Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, M5G 1X8, Canada.

Benjamin D Liu (BD)

Developmental and Stem Cell Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, M5G 0A4, Canada.
Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, M5G 1X8, Canada.

Huayun Hou (H)

Genetics and Genome Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, M5G 0A4, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, M5S 1A8, Canada.

Cadia Chan (C)

Genetics and Genome Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, M5G 0A4, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, M5S 1A8, Canada.

Andreea C Matei (AC)

Developmental and Stem Cell Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, M5G 0A4, Canada.
Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, M5G 1X8, Canada.

Areti Tzanetakis (A)

Developmental and Stem Cell Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, M5G 0A4, Canada.
Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, M5G 1X8, Canada.

Bo Li (B)

Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, M5G 1X8, Canada.
Translational Medicine Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, M5G 0A4, Canada.

Rebeca L Figueira (RL)

Laboratory of Experimental Fetal and Neonatal Surgery, Division of Pediatric Surgery, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paolo, 14049-900, Brazil.

Karina M da Costa (KM)

Laboratory of Experimental Fetal and Neonatal Surgery, Division of Pediatric Surgery, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paolo, 14049-900, Brazil.

Amy P Wong (AP)

Developmental and Stem Cell Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, M5G 0A4, Canada.

Robert Mitchell (R)

School of Biological Sciences, University of Reading, Reading RG6 6AS, UK.

Anna L David (AL)

Institute for Women's Health, University College London, London WC1E 6HU, UK.
NIHR University College London Hospitals Biomedical Research Centre, London W1T 7HA, UK.

Ketan Patel (K)

School of Biological Sciences, University of Reading, Reading RG6 6AS, UK.
FRIAS Freiburg Institute for Advanced Studies, University of Freiburg, Freiburg 79104, Germany.

Paolo De Coppi (P)

Stem Cell and Regenerative Medicine Section, Great Ormond Street Institute of Child Health, University College of London, London WC1N 1EH, UK.
NIHR Biomedical Research Centre and Specialist Neonatal and Paediatric Unit, Great Ormond Street Hospital, London WC1N 1EH, UK.

Lourenço Sbragia (L)

Laboratory of Experimental Fetal and Neonatal Surgery, Division of Pediatric Surgery, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paolo, 14049-900, Brazil.

Michael D Wilson (MD)

Genetics and Genome Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, M5G 0A4, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, M5S 1A8, Canada.

Janet Rossant (J)

Developmental and Stem Cell Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, M5G 0A4, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, M5S 1A8, Canada.

Augusto Zani (A)

Developmental and Stem Cell Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, M5G 0A4, Canada. augusto.zani@sickkids.ca.
Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, M5G 1X8, Canada.
Department of Surgery, University of Toronto, Toronto, M5T 1P5, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH